產品描述: | PX-478 is an orally active HIF-1α inhibitor with potent antitumor activities. PX-478 can cross the blood-brain barrier |
靶點: |
HIF-1α;HIF/HIFProlyl-Hydroxylase;?HIF;?Autophagy |
體內研究: |
PX-478 is administered to mice with congenital HO (Nfatc1-Cre/caACVR1fl/fl) every other day starting from birth for 2 wk. Treated mice have significantly less ectopic bone at the ankle joints compared with mutant mice treated with vehicle (6.8 mm3?vs. 2.2 mm3, P<0.01) |
參考文獻: |
1. Palayoor ST, et al. PX-478, an inhibitor of hypoxia-inducible factor-1alpha, enhances radiosensitivity of prostate carcinoma cells. Int J Cancer. 2008 Nov 15;123(10):2430-2437. 2. Agarwal S, et al. Inhibition of Hif1α prevents both trauma-induced and genetic heterotopic ossification. Proc Natl Acad Sci U S A. 2016 Jan 19;113(3):E338-47. |
溶解性: |
DMSO : 100 mg/mL (253.73 mM; Need ultrasonic) H2O : ≥ 35 mg/mL (88.81 mM) |
保存條件: |
-20℃,氮氣保存 |
配置溶液濃度參考: |
|
1mg |
5mg |
10mg |
1 mM |
2.537 ml |
12.686 ml |
25.372 ml |
5 mM |
0.507 ml |
2.537 ml |
5.074 ml |
10 mM |
0.254 ml |
1.269 ml |
2.537 ml |
50 mM |
0.051 ml |
0.254 ml |
0.507 ml |
|
注意: |
部分產品我司僅能提供部分信息,我司不保證所提供信息的權威性,僅供客戶參考交流研究之用。 |